Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo
Cart
header search
Search
Skip Nav Destination
Blood Advances Cover Image for Volume 9, Issue 8
Current Issue
Volume 9,
Issue 8,
April 22 2025
View This Issue

Latest Articles

Taking a break: a therapeutic option for ECD?
Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study
Factors associated with early quality-of-life response to palliative care during hematopoietic cell transplantation
Metabolically aberrant extracellular mitochondria induce oxidative endotheliopathy in traumatic brain injury
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
Cellular and biochemical heterogeneity contributes to the phenotypic diversity of transfusion-dependent β-thalassemia
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia
Diagnosis, management, and outcomes of drug-induced erythrocytosis: a systematic review

Advertisement intended for health care professionals

17,000 citations
earned in 2023

Acknowledgement of Reviewers 2024 
ASH Commitment to Diversity, Equity, and Inclusion in Health Care

Featured Content

Audit of B-cell cancer genes

Fedratinib in 2025 and beyond: indications and future applications

Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial

C3 as a predictive and prognostic biomarker in adult hemophagocytic lymphohistiocytosis: a large cohort study in China

Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)

Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals